A pharmacist has once-again gone viral on TikTok after revealing which popular over-the-counter medicine you should avoid ...

CVS Health (NYSE: CVS) isn't having a good year. It is facing multiple headwinds and slow revenue growth, and investors are reacting in kind. The company's shares are down by 26% since January.

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

The fall of 2023 was filled with frustration from customers across Kansas City forced to find new pharmacy options.

Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...

Kansas City pharmacists walked off the job last September to protest working conditions and brought widespread attention to the troubled retail pharmacy business. The industry is battling economic ...

We recently compiled a list of the 10 Best Fortune 500 Stocks To Buy Now. In this article, we are going to take a look at ...

CVS trades below 9x forward PE, indicating it’s priced for further deterioration, but historically and relatively cheap vs.